Intracoronary stem cell injection improves post-MI ventricular function
Article Thumbnail ImageDecember 2, 2009 -- NEW YORK (Reuters Health), Dec 2 - Intracoronary injection of mononuclear bone marrow stem cells (BMSCs) improves left ventricular (LV) function in patients with ST-elevation myocardial infarction (STEMI), say researchers from Poland in the November 15 American Journal of Cardiology.
Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • OnLine CMe/CE
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • "We should consider BMSC treatment when LV dysfunction occurs despite successful percutaneous coronary intervention in patients with large anterior MI," Dr. Michal Plewka from Medical University, Lodz, told Reuters Health.

    Dr. Plewka and colleagues used transthoracic echocardiography and speckle tracking imaging to assess LV systolic and diastolic function after intracoronary BMSC injection in 60 patients with a first anterior wall STEMI treated with percutaneous coronary intervention.

    During six months of follow-up, there were two cardiac-related deaths in the BMSC group and two in the control group, the authors report.

    There were significant improvements in systolic myocardial velocities of LV basal segments in the BMSC group, but not in the control group.

    LV ejection fraction improved significantly more in the BMSC group (10%) than in the control group (5%).

    The BMSC group also had significant improvement in the mean average 2-dimensional systolic strain, whereas the improvement in the control group was not significant.

    Moreover, the researchers note, BMSC injection was associated with improvements in diastolic function parameters, including early filling propagation velocity, early diastolic velocity, and the ratio of transmitral flow velocity to annular velocity.

    "To investigate the safety and efficacy of intracoronary injection of mononuclear BMSCs, we have completed and are preparing now 2-year clinical follow-up data of our group for publication," Dr. Plewka said. "The results in terms of safety and combined clinical end-point are encouraging."

    By Will Boggs, MD

    Am J Cardiol 2009;104:1336-1342.

    Last Updated: 2009-12-01 16:08:49 -0400 (Reuters Health)

    Related Reading

    Stem cells reduce myocardial infarction size, November 21, 2006

    Copyright © 2009 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.


    || About || Advertising || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2013 || Education || Equipment Classifieds || Facebook || Forums || Home || Links || Marketplace || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2012 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2013 AuntMinnie.com. All Rights Reserved.